13,28,29 Other studies have not been able to confirm these results.23,24 Recent studies on elexacaftor/tezacaftor/ivacaftor, the most common and most effective CFTR modulator, showed a significant reduction in CF key pathogens; the limitation of these studies is the low number of participants.18,19,30. Here, CFTR is linked to cystic fibrosis.